![](https://bri.ucla.edu/wp-content/uploads/2023/08/Kate-Taylor-pic.jpg)
Kate Wolitzky-Taylor, Ph.D.
Associate Professor
kbtaylor@mednet.ucla.edu
Joanne and George Miller and Family Endowed Chair
UCLA Department of Psychiatry and Biobehavioral Sciences
Integrated Substance Use and Addiction Programs, Semel Institute of Neuroscience and Human Behavior
UCLA STAND ALACRITY Center, Center co-Director
Associate Director, UCLA Anxiety and Depression Research Center
Publications
- Wolitzky-Taylor K. Integrated behavioral treatments for comorbid anxiety and substance use disorders: A model for understanding integrated treatment approaches and meta-analysis to evaluate their efficacy.. Drug and alcohol dependence, 2023.
- Wolitzky-Taylor K, Mooney LJ, Otto MW, Metts A, Parsons EM, Hanano M, Ram R. Augmenting the efficacy of benzodiazepine taper with telehealth-delivered cognitive behavioral therapy for anxiety disorders in patients using prescription opioids: A pilot randomized controlled trial.. Contemporary clinical trials, 2023.
- Wolitzky-Taylor K, Glasner S, Tanner A, Ghahremani DG, London ED. Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept.. Behaviour research and therapy, 2022.
- Wolitzky-Taylor K, Sewart A, Karno M, Ries R, Stimson J. Development and Initial Pilot Testing of a fully integrated treatment for comorbid social anxiety disorder and alcohol use disorder in a community-based SUD clinic setting.. Behaviour research and therapy, 2021.
- Wolitzky-Taylor K, Sewart A, Zinbarg R, Mineka S, Craske MG. Rumination and worry as putative mediators explaining the association between emotional disorders and alcohol use disorder in a longitudinal study.. Addictive behaviors, 2021.
- Bleyer AJ, Kidd K, Johnson E, Robins V, Martin L, Taylor A, Pinder AJ, Bowline I, Frankova V, Živná M, Taylor KB, Kim N, Baek JJ, Hartmannová H, Hodanová K, Vyletal P, Votruba M, Kmoch S. Quality of life in patients with autosomal dominant tubulointerstitial kidney disease .. Clinical nephrology, 2019.
- Wolitzky-Taylor K, Drazdowski TK, Niles A, Roy-Byrne P, Ries R, Rawson R, Craske MG. Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.. Behaviour research and therapy, 2018.
- Wolitzky-Taylor K, Niles AN, Ries R, Krull JL, Rawson R, Roy-Byrne P, Craske M. Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders.. Behaviour research and therapy, 2018.
- Wolitzky-Taylor K, Fenwick K, Lengnick-Hall R, Grossman J, Bearman SK, Arch J, Miranda J, Chung B. A Preliminary Exploration of the Barriers to Delivering (and Receiving) Exposure-Based Cognitive Behavioral Therapy for Anxiety Disorders in Adult Community Mental Health Settings.. Community mental health journal, 2018.
- Wolitzky-Taylor K, Chung B, Bearman SK, Arch J, Grossman J, Fenwick K, Lengnick-Hall R, Miranda J. Stakeholder Perceptions of the Barriers to Receiving and Delivering Exposure-Based Cognitive Behavioral Therapy for Anxiety Disorders in Adult Community Mental Health Settings.. Community mental health journal, 2018.